These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3764 related articles for article (PubMed ID: 4701271)

  • 21. Effects of thymidine analogues on murine and human cells.
    Smellie SG; Parsons PG
    Aust J Exp Biol Med Sci; 1979 Dec; 57(6):563-73. PubMed ID: 162036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between rejection of several syngeneic tumors and retrovirus production by 5-bromodeoxyuridine-grown melanoma cells: lack of protection in natural killer-deficient beige mice.
    Silagi S; Calvelli TA
    Cancer Res; 1982 Jul; 42(7):2562-6. PubMed ID: 7083149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A human melanoma line heterogeneous with respect to metastatic capacity in athymic nude mice.
    Kozlowski JM; Hart IR; Fidler IJ; Hanna N
    J Natl Cancer Inst; 1984 Apr; 72(4):913-7. PubMed ID: 6584666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of cortisol and BUDR on cellular differentiation in the small intestine in suckling rats.
    Clark SL
    Am J Anat; 1971 Nov; 132(3):319-37. PubMed ID: 5115521
    [No Abstract]   [Full Text] [Related]  

  • 25. Bromodeoxyuridine (BUdR) treatment of melanoma cells decreases cellular proteolytic activity.
    Evans I; Bosmann HB
    Exp Cell Res; 1977 Aug; 108(1):151-5. PubMed ID: 19270
    [No Abstract]   [Full Text] [Related]  

  • 26. Selective radiosensitization of drug-resistant MutS homologue-2 (MSH2) mismatch repair-deficient cells by halogenated thymidine (dThd) analogues: Msh2 mediates dThd analogue DNA levels and the differential cytotoxicity and cell cycle effects of the dThd analogues and 6-thioguanine.
    Berry SE; Davis TW; Schupp JE; Hwang HS; de Wind N; Kinsella TJ
    Cancer Res; 2000 Oct; 60(20):5773-80. PubMed ID: 11059773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of incorporation of 5-halogenated deoxyuridines into the DNA of eukaryotic cells.
    Goz B
    Pharmacol Rev; 1977 Dec; 29(4):249-72. PubMed ID: 364496
    [No Abstract]   [Full Text] [Related]  

  • 28. Incorporation of 5-bromo-2'-deoxyuridine into mesenchymal limb-bud cells destined to die: relationship to polydactyly induction in rats.
    Wise LD; Scott WJ
    J Embryol Exp Morphol; 1982 Dec; 72():125-41. PubMed ID: 6763934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in cell density associated with differences in lung-colonizing ability of B16 melanoma cells.
    Baniyash M; Netanel T; Witz IP
    Cancer Res; 1981 Feb; 41(2):433-7. PubMed ID: 7448787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of malignancy and differentiation in melanotic melanoma cells.
    Silagi S; Bruce SA
    Proc Natl Acad Sci U S A; 1970 May; 66(1):72-8. PubMed ID: 4921328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of 5-bromodeoxyuridine on hyaluronic acid synthesis of a clonal hybrid line of mouse and chinese hamster in culture.
    Koyama H; Ono T
    J Cell Physiol; 1971 Oct; 78(2):265-71. PubMed ID: 4258000
    [No Abstract]   [Full Text] [Related]  

  • 32. Multimodality imaging of IL-18--binding protein-Fc therapy of experimental lung metastasis.
    Cao Q; Cai W; Niu G; He L; Chen X
    Clin Cancer Res; 2008 Oct; 14(19):6137-45. PubMed ID: 18829492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incorporation of 5-bromodeoxyuridine and 5-iododeoxyuridine into viral DNA and its effect on the infective process.
    Kaplan AS; Benporat T; Kamiya T
    Ann N Y Acad Sci; 1965 Jul; 130(1):226-39. PubMed ID: 5216629
    [No Abstract]   [Full Text] [Related]  

  • 34. A clonal study of the reversible inhibition of muscle differentiation by the halogenated thymidine analog 5-bromodeoxyuridine.
    Coleman JR; Coleman AW; Hartline EJ
    Dev Biol; 1969 Jun; 19(6):527-48. PubMed ID: 5772670
    [No Abstract]   [Full Text] [Related]  

  • 35. Recent observations on the pathogenesis of cancer metastasis.
    Fidler IJ; Hart IR
    Prog Clin Biol Res; 1982; 85 Pt B():601-19. PubMed ID: 6750636
    [No Abstract]   [Full Text] [Related]  

  • 36. Novel phenotypes arising from selection of hamster melanoma cells for resistance to BUdR.
    Kaufman ER; Davidson RL
    Exp Cell Res; 1977 Jun; 107(1):15-24. PubMed ID: 558895
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of thymidine analogs upon growth control in cultured hormone-dependent ray ovary cells.
    Mathews CK
    Exp Cell Res; 1975 Apr; 92(1):39-46. PubMed ID: 124255
    [No Abstract]   [Full Text] [Related]  

  • 38. The selection and induction of 5-iodo-2-deoxyuridine and thymidine variants of P388 mouse lymphoma cells with agents which are used for selection.
    Anderson D
    Mutat Res; 1975 Dec; 33(2-3):399-405. PubMed ID: 1214830
    [No Abstract]   [Full Text] [Related]  

  • 39. Possible role of cell kinetics in prediction of the response to cancer therapy.
    Tannock I; Frei E
    Natl Cancer Inst Monogr; 1971 Dec; 34():19-24. PubMed ID: 5140864
    [No Abstract]   [Full Text] [Related]  

  • 40. Inhibition of myogenesis in a rat myoblast line by 5-bromodeoxyuridine.
    Rogers J; Ng SK; Coulter MB; Sanwal BD
    Nature; 1975 Jul; 256(5516):438-40. PubMed ID: 1170504
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 189.